Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $149.12 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $149.12 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39.44 | 2 | Janssen Pharmaceuticals, Inc ($39.44) |
| 2021 | $109.68 | 1 | Janssen Pharmaceuticals, Inc ($109.68) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Neuroscience | ||||||
| 05/09/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Neuroscience | ||||||
| 10/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 314 | 321 | $617,466 | $45,235 |
| 2022 | 18 | 1,489 | 1,634 | $1.0M | $244,468 |
| 2021 | 19 | 3,352 | 3,457 | $950,015 | $234,241 |
| 2020 | 6 | 688 | 705 | $986,477 | $104,666 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 216 | 221 | $458,796 | $32,401 | 7.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 65 | 66 | $81,048 | $6,438 | 7.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 34 | $77,622 | $6,395 | 8.2% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 176 | 176 | $126,470 | $64,535 | 51.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 246 | 251 | $505,765 | $42,579 | 8.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 181 | 181 | $62,445 | $31,983 | 51.2% |
| Q0222 | Injection, bebtelovimab, 175 mg | Office | 2022 | 176 | 176 | $39,002 | $30,501 | 78.2% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 26 | 26 | $18,550 | $12,066 | 65.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $21,500 | $10,249 | 47.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 38 | 38 | $84,208 | $8,503 | 10.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 167 | 241 | $36,150 | $8,264 | 22.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 93 | 93 | $11,625 | $7,089 | 61.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 112 | $10,640 | $6,834 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 62 | $10,850 | $5,970 | 55.0% |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | Office | 2022 | 33 | 35 | $10,500 | $5,535 | 52.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 44 | 45 | $53,640 | $4,824 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 31 | $8,525 | $4,198 | 49.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 12 | 12 | $8,364 | $681.93 | 8.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 16 | 16 | $1,360 | $655.36 | 48.2% |
| Q0221 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | Office | 2022 | 26 | 28 | $0.28 | $0.28 | 100.0% |
| Q0247 | Injection, sotrovimab, 500 mg | Office | 2022 | 25 | 25 | $0.25 | $0.24 | 96.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 366 | 366 | $84,240 | $44,681 | 53.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 237 | 243 | $431,325 | $43,212 | 10.0% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 885 | 885 | $75,115 | $26,363 | 35.1% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 54 | 54 | $36,140 | $25,929 | 71.7% |
About Dr. Jeffrey Bohmer, M.D
Dr. Jeffrey Bohmer, M.D is a Emergency Medicine healthcare provider based in Geneva, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609951979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Bohmer, M.D has received a total of $149.12 in payments from pharmaceutical and medical device companies, with $39.44 received in 2023. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Food and Beverage" ($149.12).
As a Medicare-enrolled provider, Bohmer has provided services to 5,843 Medicare beneficiaries, totaling 6,117 services with total Medicare billing of $628,610. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Geneva, IL
- Active Since 10/26/2006
- Last Updated 05/20/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1609951979
Products in Payments
- XARELTO (Drug) $109.68
- SPRAVATO (Drug) $39.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Geneva
Shahram Ahari
Emergency Medicine — Payments: $701.32
Arnold Del Mundo, M.d, M.D
Emergency Medicine — Payments: $132.86
Dr. Matthew Talbott, M.d, M.D
Emergency Medicine — Payments: $125.14
Ramiro Ramos, M.d, M.D
Emergency Medicine — Payments: $109.71
Steven Coker, M.d, M.D
Emergency Medicine — Payments: $61.42
Dr. Virgil Smaltz, Md, MD
Emergency Medicine — Payments: $42.69